Counterpoint Mutual Funds’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $906K | Buy |
+78,249
| New | +$906K | 0.08% | 57 |
|
|
2024
Q4 | $742K | Buy |
+51,658
| New | +$742K | 0.09% | 74 |
|
|
2024
Q3 | – | Sell |
-10,861
| Closed | -$211K | – | 377 |
|
|
2024
Q2 | $211K | Buy |
+10,861
| New | +$211K | 0.05% | 176 |
|
|
2023
Q4 | – | Sell |
-5,177
| Closed | -$214K | – | 292 |
|
|
2023
Q3 | $214K | Buy |
5,177
+3,323
| +179% | +$137K | 0.18% | 54 |
|
|
2023
Q2 | $104K | Buy |
+1,854
| New | +$104K | 0.1% | 229 |
|